ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD)
- DOI
- 10.1186/s13063-026-10022-z
- Published
- 2026-10-20
- Container
- Trials
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-026-10022-z,
title = {ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD)},
author = {Friederike Ufer and Rosa Rössling and Annika Spottke and Robert Németh and Tamara Schaprian and Nadja Kemmerling-de Coninck and Anna Gamez and Rebecca Sterl and Pia Naumann and Nikolaus Behr and André Maier and Thomas Meyer and Patrick Weydt and Harald Prüss},
year = {2026},
journal = {Trials},
doi = {10.1186/s13063-026-10022-z},
url = {https://doi.org/10.1186/s13063-026-10022-z}
}RIS
TY - JOUR TI - ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD) AU - Friederike Ufer AU - Rosa Rössling AU - Annika Spottke AU - Robert Németh AU - Tamara Schaprian AU - Nadja Kemmerling-de Coninck AU - Anna Gamez AU - Rebecca Sterl AU - Pia Naumann AU - Nikolaus Behr AU - André Maier AU - Thomas Meyer AU - Patrick Weydt AU - Harald Prüss PY - 2026 JO - Trials DO - 10.1186/s13063-026-10022-z UR - https://doi.org/10.1186/s13063-026-10022-z ER -
APA
Ufer, F., Rössling, R., Spottke, A., Németh, R., Schaprian, T., Coninck, N. K., Gamez, A., Sterl, R., Naumann, P., Behr, N., Maier, A., Meyer, T., Weydt, P., & Prüss, H. (2026). ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD). Trials. https://doi.org/10.1186/s13063-026-10022-z
Source records
- crossref · retrieved 2026-11-05T08:49:48.197Z